In the February 2011 issue, the article entitled “Genzyme, though unique, could be a bellwether for US biotech” (Nat. Med. 17, 145, 2011) incorrectly stated that GlaxoSmithKline had acquired AstraZeneca. Although GlaxoSmithKline has acquired medicines from AstraZeneca in the past, the two companies never merged. The error has been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nm0211-145
Rights and permissions
About this article
Cite this article
Correction: 'Genzyme, though unique, could be a bellweather for US biotech'. Nat Med 17, 237 (2011). https://doi.org/10.1038/nm0311-237b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0311-237b
